SEC Stock Data

Quick Answer Ascend Wellness Holdings, Inc. reported Total Revenue of $500.58 million for fiscal year 2025. Ascend Wellness Holdings, Inc. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $500.58M-10.9% $561.60M+8.3% $518.59M+27.8% $405.93M+22.1% $332.38M+131.3% $143.73M+1094.6% Net Income — — — -$80.90M+34.0% -$122.66M-382.2% -$25.44M+20.2% Diluted EPS -$0.58-45.0% -$0.40-66.7% -$0.24+45.5% -$0.44+46.3% -$0.82-203.7% … Read more

Quick Answer Abivax S.A. reported R&D Expense of $177.76 million for fiscal year 2025. Abivax S.A. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $177.76M +21.3% 2024 $146.53M +42.0% 2023 $103.18M +113.6% 2022 $48.30M +1.1% 2021 $47.78M — Abivax S.A. showed an increase of +21.3% in R&D Expense compared to the … Read more

Quick Answer Abivax S.A. reported Total Assets of $584.34 million for fiscal year 2025. Abivax S.A. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $584.34M +184.7% 2024 $205.23M -37.3% 2023 $327.06M +332.9% 2022 $75.54M -30.8% 2021 $109.23M — Abivax S.A. showed an increase of +184.7% in Total Assets compared to the … Read more

Quick Answer Abivax S.A. reported Total Assets of $584.34 million for fiscal year 2025. Abivax S.A. — Key Financials by Year Metric 2025 2024 2023 2022 2021 Total Assets $584.34M+184.7% $205.23M-37.3% $327.06M+332.9% $75.54M-30.8% $109.23M R&D Expense $177.76M+21.3% $146.53M+42.0% $103.18M+113.6% $48.30M+1.1% $47.78M Abivax S.A. reported Total Assets of $584.34 million for fiscal year 2025. Abivax S.A. … Read more

Quick Answer ALMADEN MINERALS LTD reported Total Assets of $6.69 million for fiscal year 2025. ALMADEN MINERALS LTD Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $6.69M -43.2% 2024 $11.78M -7.3% 2023 $12.71M -83.7% 2022 $78.05M -10.5% 2021 $87.23M +14.1% 2020 $76.45M +3.2% 2019 $74.06M +0.2% 2018 $73.93M +10.7% 2017 $66.80M … Read more

Quick Answer ALMADEN MINERALS LTD reported Total Assets of $6.69 million for fiscal year 2025. ALMADEN MINERALS LTD — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Assets $6.69M-43.2% $11.78M-7.3% $12.71M-83.7% $78.05M-10.5% $87.23M+14.1% $76.45M+3.2% ALMADEN MINERALS LTD reported Total Assets of $6.69 million for fiscal year 2025. ALMADEN MINERALS LTD showed … Read more

Quick Answer AUTOSCOPE TECHNOLOGIES CORP reported Shares Outstanding of 5.38 million shares for fiscal year 2021. AUTOSCOPE TECHNOLOGIES CORP Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2021 5.38M +0.5% 2020 5.35M +0.6% 2019 5.32M +0.8% 2018 5.28M +1.3% 2017 5.21M +2.3% 2016 5.09M +1.3% 2015 5.03M +0.6% 2014 5.00M +0.4% 2013 … Read more

Quick Answer AUTOSCOPE TECHNOLOGIES CORP reported Gross Profit of $10.23 million for fiscal year 2021. AUTOSCOPE TECHNOLOGIES CORP Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2021 $10.23M -1.5% 2020 $10.39M -10.5% 2019 $11.60M -1.5% 2018 $11.78M +1.5% 2017 $11.60M +15.5% 2016 $10.04M -14.4% 2015 $11.74M -13.4% 2014 $13.56M +1.0% 2013 $13.42M … Read more

Quick Answer AUTOSCOPE TECHNOLOGIES CORP reported Operating Income of $2.27 million for fiscal year 2021. AUTOSCOPE TECHNOLOGIES CORP Operating Income — Annual History Fiscal Year Operating Income YoY Change 2021 $2.27M +273.8% 2020 $608.0K -66.8% 2019 $1.83M -1.2% 2018 $1.85M -12.7% 2017 $2.12M +208.9% 2016 $687.0K +80.8% 2015 $380.0K +116.9% 2014 -$2.25M +69.7% 2013 -$7.44M … Read more

Quick Answer AUTOSCOPE TECHNOLOGIES CORP reported R&D Expense of $2.21 million for fiscal year 2021. AUTOSCOPE TECHNOLOGIES CORP R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2021 $2.21M -33.6% 2020 $3.34M +17.6% 2019 $2.84M -13.6% 2018 $3.28M +9.1% 2017 $3.01M +2.2% 2016 $2.95M -16.3% 2015 $3.52M -27.6% 2014 $4.86M +31.1% 2013 $3.71M … Read more